{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:18:17Z","timestamp":1787318297161,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) represents a significant global health burden. Its pathogenesis is closely linked to a state of metabolic inflammation, involving insulin resistance and chronic low-grade inflammation. The high-sensitivity C-reactive protein-triglyceride glucose index (CTI) is a novel composite biomarker integrating inflammatory and metabolic information, yet its association with CKD in the general population remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the cross-sectional association between the CTI and the prevalence of CKD in a health examination population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 10\u2013287 adults who underwent routine health check-ups were included. The CTI was calculated as the product of high-sensitivity C-reactive protein (hs-CRP) and the triglyceride-glucose (TyG) index. CKD was defined as an estimated glomerular filtration rate (eGFR) &amp;lt;60 mL\/min\/1.73 m\u00b2. Logistic regression models were used to assess the association of CTI (as a continuous variable and in quartiles) with CKD. Diagnostic performance was evaluated using the area under the receiver operating characteristic curve (AUC). The shape of the association and its heterogeneity were explored using restricted cubic splines and subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 163 (1.58%) participants were identified as CKD. After full adjustment for confounders, each unit increase in CTI was associated with a 2.25-fold increased odds of CKD (OR = 2.25, 95%CI: 1.66\u20133.06). Compared to participants in the lowest CTI quartile, those in the highest quartile had a 2.17-fold higher risk of CKD (OR = 2.17, 95% CI: 1.25\u20133.76;\n                      <jats:italic>P<\/jats:italic>\n                      for trend = 0.001). A nonlinear dose-response relationship was observed between CTI and CKD (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity = 0.012). The CTI demonstrated superior diagnostic performance for CKD (AUC = 0.69, 95% CI: 0.64\u20130.73) compared to its individual components, the TyG index (AUC = 0.66) and hs-CRP (AUC = 0.59). Subgroup analyses revealed that the association was particularly pronounced in males, individuals aged &amp;lt;60 years, and those with a history of alcohol consumption.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In a health examination population, a higher CTI level was independently and nonlinearly associated with an increased prevalence of CKD, and it showed better diagnostic performance than individual inflammatory or metabolic markers alone. The CTI may serve as a useful tool for identifying individuals at high risk for CKD, especially for early risk stratification in specific subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1781798","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:22:42Z","timestamp":1770960162000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of high sensitivity C-reactive protein-triglyceride glucose index and chronic kidney disease: a cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Fengxu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.akdh.2024.07.004","article-title":"Chronic kidney disease-part 1: evaluation & Risk assessment in CKD, methods to delay CKD progression","volume":"31","author":"Larsen","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101275","article-title":"Characteristics of patients with undiagnosed stage 3 chronic kidney disease: results from an observational study (REVEAL-CKD) in China","volume":"54","author":"Nie","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biom15121745","article-title":"Insulin resistance at the crossroads of metabolic inflammation, cardiovascular disease, organ failure and cancer","volume":"15","author":"Lonardo","year":"2025","journal-title":"Biomolecules"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1769-7255(09)75168-5","article-title":"Insulino r\u00e9sistance et inflammation en insuffisance r\u00e9nale [Insulin resistance and inflammation in chronic kidney diseases","author":"Guebre-Egziabher","year":"2009","journal-title":"Nephrol Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1179834","article-title":"Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate \u201cdiseased\u201d from \u201cnormal","volume":"10","author":"Kataoka","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1007-9572.2016.27.003","article-title":"Study on factors related to insulin resistance in IgA nephropathy","volume":"19","author":"Lin","year":"2016","journal-title":"Chin Gen Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3969\/j.issn.1671-2390.y20-119","article-title":"Research advances in triglyceride-glucose product index with chronic kidney disease and coronary artery lesions","volume":"21","author":"Guan","year":"2021","journal-title":"J Clin Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/a-2634-0157","article-title":"Relationship between the triglyceride-glucose index and chronic kidney disease: A meta-analysis of cohort studies","volume":"57","author":"Wang","year":"2025","journal-title":"Horm Metab Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000534034","article-title":"Association between the high-sensitivity C-reactive protein\/albumin ratio and new-onset chronic kidney disease in chinese individuals","volume":"148","author":"Zhang","year":"2024","journal-title":"Nephron"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1008-6358.2012.05.018","article-title":"Influence of micro-inflammatory and oxidative stress on renal function in patients with chronic kidney disease","volume":"5","author":"Shen","year":"2012","journal-title":"Chin J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e017980","DOI":"10.1161\/JAHA.120.017980","article-title":"Low high-sensitivity C-reactive protein level in korean patients with chronic kidney disease and its predictive significance for cardiovascular events, mortality, and adverse kidney outcomes: results from KNOW-CKD","volume":"9","author":"Lee","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1485538","article-title":"Usefulness of C-reactive protein-triglyceride glucose index in detecting prevalent coronary heart disease: findings from the National Health and Nutrition Examination Survey 1999-2018","volume":"11","author":"Xu","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1511319","article-title":"The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity","volume":"16","author":"Wan","year":"2025","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","article-title":"Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study","volume":"23","author":"Cui","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","article-title":"A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer","volume":"13","author":"Ruan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.04.001","article-title":"Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study","volume":"33","author":"Feng","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1602594","article-title":"Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy","volume":"16","author":"Hou","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.113","article-title":"NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy","volume":"84","author":"Du","year":"2013","journal-title":"Kidney Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s13679-024-00583-y","article-title":"The kidney in obesity: current evidence, perspectives and controversies","volume":"13","author":"Kounatidis","year":"2024","journal-title":"Curr Obes Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/IJNRD.S39739","article-title":"Obesity, hypertension, and chronic kidney disease","volume":"7","author":"Hall","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa336","article-title":"Obesity, kidney dysfunction, and inflammation: interactions in hypertension","volume":"117","author":"Hall","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114520002275","article-title":"Consumption of whole purple and regular wheat modestly improves metabolic markers in adults with elevated high-sensitivity C-reactive protein: a randomized, single-blind parallel-arm study","volume":"124","author":"Gamel","year":"2020","journal-title":"Br J Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.redox.2017.08.019","article-title":"Role of glutathione biosynthesis in endothelial dysfunction and fibrosis","volume":"14","author":"Espinosa-D\u00edez","year":"2018","journal-title":"Redox Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-016-0281-z","article-title":"The pathological significance of dipeptidyl peptidase-4 in endothelial cell homeostasis and kidney fibrosis","volume":"7","author":"Kanasaki","year":"2016","journal-title":"Diabetol Int"},{"key":"B30","first-page":"4","article-title":"NF-\u03baB signaling pathway and insulin resistance","volume":"29","author":"Hua","year":"2009","journal-title":"J Shanghai Jiaotong Univ (Med Sci)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174884","article-title":"HM-chromanone attenuates TNF-\u03b1-mediated inflammation and insulin resistance by controlling JNK activation and NF-\u03baB pathway in 3T3-L1 adipocytes","volume":"921","author":"Park","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/nu16020294","article-title":"Improving the effect of ferulic acid on inflammation and insulin resistance by regulating the JNK\/ERK and NF-\u03baB pathways in TNF-\u03b1-treated 3T3-L1 adipocytes","volume":"16","author":"Park","year":"2024","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0312374","DOI":"10.1371\/journal.pone.0312374","article-title":"Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes","volume":"19","author":"Li","year":"2024","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/met.2023.0188","article-title":"Triglyceride-glucose index and its correlates: associations with serum creatinine and estimated glomerular filtration rate in a cross-sectional study from CHARLS 2011-2015","volume":"22","author":"Li","year":"2024","journal-title":"Metab Syndr Relat Disord"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-04103-8","article-title":"Association between triglyceride-glucose index and chronic kidney disease: results from NHANES 1999-2020","volume":"56","author":"Li","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.06.019","article-title":"High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients","volume":"216","author":"Fu","year":"2019","journal-title":"Am Heart J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5551\/jat.64047","article-title":"Impact of C-reactive protein on long-term cardiac events in stable coronary artery disease patients with chronic kidney disease","volume":"30","author":"Tokuda","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S496703","article-title":"The clinical value of the combined detection of systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and prognostic nutritional index (PNI) in early diagnosis of gastric cancer","volume":"18","author":"Zheng","year":"2025","journal-title":"J Inflammation Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00775-0","article-title":"Oxidative stress and the role of redox signaling in chronic kidney disease","volume":"20","author":"Kishi","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8184","article-title":"Inflammation and oxidative stress in chronic kidney disease and dialysis patients","volume":"35","author":"Ebert","year":"2021","journal-title":"Antioxid Redox Signal"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1781798\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:22:44Z","timestamp":1770960164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1781798\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":40,"alternative-id":["10.3389\/fendo.2026.1781798"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1781798","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"article-number":"1781798"}}